a single immunization with 3-4 × 10 ~ allogeneic GAT-Mq~ bearing ~ 100-150 ng GAT. Thus, we investigated whether suppressor cells are present in these genetically restricted immune lymphoid cells and whether these suppressor cells may account for the failure of immune spleen cells to develop primary PFC responses to GAT-Mdp allogeneic to the M~ used for the initial immunization in vivo. These investigations are the subject of this communication.
Materials and Methods
Mice. C57BL/10 (H-2b), C3H/He (H-2k), B10.D2 (H-2a), DBA/2 (H-2a), and DBA/1 (H2q) mice were bred in the Animal Facility in the Yalem Building at The Jewish Hospital of St.
Louis. All mice were maintained on laboratory chow and water ad libitum and used at 10-20 wk old. In a single experiment, mice were sex-and age-matched. DBA/1 mice are nonresponders to GAT; all other mice are responder strains.
Antigens. GAT (Miles Laboratories Inc., Miles Research Products, Elkhart, Ind.; lot 4, mol wt ~45,000) was prepared as previously described for use as antigen in culture (10) , for preparing GAT-Mdp (2) , and for coupling to sheep erythrocytes (SRBC) for use as indicator cells in the PFC assay (10) . SRBC (Grand Island Biological Co., Grand Island, N. Y.) were prepared for use as antigen in culture and indicator cells in the PFC assay as previously described (11) .
Culture System and Hemolytic Plaque Assay. Single-cell suspensions of spleen, at 107 cells/ml (or at other cell densities as indicated), in completely supplemented Eagle's minimal essential medium containing 10% fetal calf serum (Reheis Chemical Co., Division of Armour Pharmaceutical Co., Chicago, Ill.; lot M26302) were incubated as 1-ml cultures with GAT, GAT-Mq~, or SRBC for 5 days under modified Mishell-Dutton conditions (2, 11) . Deviations from this protocol and separation and treatment of Mq~, T-cell, and B-cell populations are described below. IgM and IgG PFC responses to SRBC and IgG GAT-specific PFC responses were assayed using the slide modification of the Jerne hemolytic plaque assay (10, 11) . Viable cell recovery was monitored using trypan blue dye exclusion and a Cytograf 6300A (Ortho Instruments, Westwood, Mass.).
Preparation of GA T-Md O and Immunization of Mice.
The preparation of GAT-M@ using peptoneinduced peritoneal exudate has been described in detail previously (2, 12) . C57BL/10 mice 6 were immunized by a single intraperitoneal injection of 3-4 X 10 ' of the indicated GAT-M~ 6 
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bearing ~20-30 ng GAT/10 cells as quantitated by I-GAT bound to Mdo (12) . Spleen cells from these mice were used in culture 21-35 days later. GAT-M~ for stimulation of PFC responses in vitro were prepared identically and 7 or 5 × 104 M@ bearing -~1-2 ng GAT were added to culture. In some experiments, peritoneal exudate Mff were treated with anti-Thy 1.2 sera and guinea pig complement (C) (lacking nonspecific cytotoxic activity on murine cells) to deplete T cells or 1,000 rads X-irradiation before pulsing with GAT. Other GAT-M4~ were incubated after pulsing for 24 h at 37°C in 5% CO2 in air, washed, and then used to stimulate PFC responses in culture (aged GAT-Mff). Md~ content in the various GAT-Mq~ preparations was monitored by latex sphere ingestion. Freshly pulsed GAT-Mff preparations had a minimum of 85% phagocytic cells; anti-Thy 1.2 + C treated and aged GAT-Mq~ preparations had ->90% and _>95% phagocytic cells, respectively. (Table I ) and syngeneic (Table  II) * The indicated number of virgin or immune C57BL/10 spleen cells were cultured with 7 × 104 of the indicated GAT-Mq~ bearing m2 ng GAT, or GAT-M~ plus 5 × 106 SRBC. :~ C57BL/10 mice were immunized 28 days previously by intraperitoneal injection of 3 × 106 C57BL/10 GAT-M¢ bearing m30 ng GAT/106 cells. At culture initiation, these spleen cells had <25 IgG GATspecific PFC/107 cells.
Preparation of T-and B-Cell
occasionally larger numbers of cells were required to achieve significant suppression (Table I , exp. 1). Suppressor cell activity was always observed with third party GATMq~ (C3H/He Mq~ in Table I and B10.D2 Mq~ in Table II ) unrelated by H-2 haplotype to either the responding spleen cells or the GAT-Mq~ used for in vivo priming. The suppression was antigen-specific; primary IgM (data not shown) and IgG PFC responses to SRBC were not suppressed by the immune spleen cells in the presence of GAT-M$ which induced suppression of the GAT-specific primary response (Table II) .
Characterization of the Suppressor Cell. The suppressor cells in genetically restricted
immune spleen cells were characterized as T cells by two methods. First, immune spleen cells were separated into T and B cells by adsorption to and elution from a rabbit anti-mouse Ig Sepharose 4B column (Table III) . Purified T cells, but not B cells, suppressed responses of virgin spleen cells stimulated by GAT-Mq~ allogeneic to those used to prime the restricted immune spleen cells. Here, C57BL/10 GAT-Mq~ were used for immunization and DBA/1 GAT-M4~ elicited suppressor cell activity. Second, the suppressive activity in restricted immune spleen cells was abrogated by treatment with anti-Thy 1.2 serum plus C demonstrating, by a subtractive procedure, that the suppressor cells are T cells (Table IV) . Lastly, suppressor T-cell function was radiosensitive, because 800 rads X-irradiation abolished their activity (Table IV) . Thus, suppressor cell activity in restricted immune spleen cells is a property of radiosensitive, antigen-specific T cells.
Allogeneic T Cells Contaminating the GAT-M¢~ are not Responsible for the Suppression.
Suppressor T cells in immune spleen cells that are restricted for the ailogeneic GAT-M~ are stimulated by syngeneic GAT-Mq~ in vitro (Table I) ; here, exposure to allogeneic cells is limited to the in vivo immunization process. However, suppressor T cells in immune spleen cells restricted for syngeneic GAT-Mq~ are activated by allogeneic GAT-Mq~ in vitro (Table II) where the exposure to allogeneic cells is during the culture and the contribution of allogeneic T cells contaminating the Mq~ preparation to the suppressive activity is important to determine. Thus, M~ populations were treated with anti-Thy 1.2 serum plus C before pulsing with GAT to deplete T cells under the same conditions used in Table IV to deplete T cells from immune spleen cell populations. The resulting M4~ preparations were --90% phagocytic by latex bead ingestion and bound approximately equivalent amounts of GAT as normal control M~, i.e., "2 ng/105 cells. Normal and T-cell-depleted C57BL/10 and DBA/2 GAT-M~ stimulated comparable primary PFC responses by virgin C57BL/10 spleen cells, secondary responses by immune spleen cells restricted for syngeneic C57BL/10 GAT-Mq~, and suppressor cell activity in primary responses when these immune cells were stimulated with allogeneic DBA/2 GAT-M~ (Table  V) . Identical results were obtained with M~ preparations X-irradiated (1,000 rads) before pulsing with GAT (data not shown). Another more indirect approach to this question used GAT-Mq~ which had been aged after pulsing. The T-cell depletion in this situation is by attrition, because the GAT-Mqb are incubated in medium without serum in 5% CO2 in air for 24 h. Few cells are lost by adherence to the plastic culture tubes and the recovered cells are routinely 95% phagocytic. However, --90% of the GAT originally associated with the M~ is released into the supernate as nonacid precipitable radioactivity and the Mq~ retain --0.2 ng GAT/10 ~ cells (14) . Nevertheless, these aged GAT-Mq~ behaved identically to freshly pulsed or T-cell-depleted GATM~b in terms of their ability to stimulate primary responses by virgin spleen cells, restricted responses by immune cells, and suppressor T-cell activity (Table V) . Thus, T cells contaminating the allogeneic peritoneal exudate M~ preparations used in the various protocols do not appear to contribute either to the restrictions on Mq~-immune T-lymphocyte interactions in secondary PFC responses or the activation of suppressor T cells in these immune spleen cells by an inappropriate GAT-M4~. Moreover, these results have been derived using whole unfractionated spleen cells rather than rigorously Mq~-depleted lymphoid cell populations, because depletion of Mdp does not alter the results. Further, the experiments described in Tables III-V have been carried out with identical results using spleen cells from mice immunized with allogeneic GAT-M~ where secondary responses are restricted to those allogeneic GAT-M~, and suppressor cells are stimulated by syngeneic GAT-M~ (data not shown).
TABLE

IV
Radiosensitivity of Suppressor T Cells in Restricted Immune Spleen Cells
Discussion
These experiments further characterize the immunological consequences of immunizing responder mice with GAT bound to syngeneic or allogeneic Mth. As shown previously, virgin responder spleen cells develop comparable primary PFC responses to syngeneic or allogeneic GAT-Mth, whereas immune spleen cells develop secondary PFC responses only when stimulated with GAT-Mth which are syngeneic with the M@ that presented GAT to the virgin lymphocytes during the immunization process in vivo (2, 3) . In this system, no difference between responder and nonresponder M@, with regard to their ability to present GAT in an immunogenic form to lymphoid cells, has been detected. A primary objective of the present experiments was to determine whether suppressor T cells are involved in these genetic restrictions in secondary responses and account for the failure of immune spleen cells, which should contain virgin unrestricted GAT-specific helper T cells, to develop primary PFC responses to GAT-Mth allogeneic to M~ used for in vivo immunization.
Cultures containing small numbers of spleen cells primed with syngeneic or allogeneic GAT-M~ plus virgin spleen cells develop responses only to GAT-M~ syngeneic to the priming M~ and have suppressed primary responses to GAT-Mth allogeneic to the priming M~. Thus, these primed spleen cells contain helper T cells, whose function is genetically restricted for the priming M~, and suppressor cells, whose function is apparently not restricted, that inhibit the responses of virgin spleen cells. The suppression is specific for GAT because no suppression of responses to SRBC is observed in the presence of GAT-M@ which activate the suppressor cells. The suppression is mediated by T cells from GAT-Mth primed mice and this suppressor T-cell function is relatively radiosensitive. Lastly, the possibility that a negative allogeneic effect (15) mediated by T cells contaminating the Mth preparations causing either the restriction in secondary responses or the suppression in primary responses has been ruled out.
These experiments also provide an explanation for the previous failure to demonstrate GAT-specific suppressor T cells in responder mice using experimental protocols which readily induce suppressor T cells in mice which are nonresponders to GAT (14, 16, 17) . First, in nonresponder mice soluble GAT induces suppressor T cells which inhibit primary GAT-specific responses to GAT-MBSA in the presence of syngeneic Mth; GAT-M~ are ineffective activators of these suppressor T cells, but can induce GAT-specific helper T cells (14, 18) . In responder mice, GAT-Mth and soluble GAT induce both restricted helper T cells and suppressor T cells which are only activated by GAT-Mth allogeneic to the Mth present during the in vivo priming. Second, the kinetics of development of suppressor T cells differs in responder and nonresponder mice; suppressor T cells are detected from 3 to 28 days after the injection of GAT in nonresponder mice (14, 16 ), but only 21 or more days after the injection of GAT-Mth in responder mice (C. W. Pierce, and J. A. Kapp, unpublished observations). Thus, GAT-specific suppressor T cells in responder and nonresponder mice appear to differ in both their mode and kinetics of activation. However, their mechanism of action may be similar, because they inhibit activation of virgin, but not immune, helper T 
Summary
Virgin spleen cells develop comparable primary antibody responses in vitro to syngeneic or allogeneic macrophages (M~) bearing the terpolymer L-glutamic acid 6°-c-alanineZ°-c-tyrosine 1° (GAT), whereas immune spleen cells primed with syngeneic or allogeneic GAT-M4~ develop secondary responses preferentially when stimulated with GAT-M4~ syngeneic to the GAT-M4~ used for priming in vivo. These restrictions are mediated by products of the I-A subregion of the H-2 complex and are operative at the level of the GAT-M4,-immune helper T-cell interactions. To investigate why these immune spleen cells fail to develop a significant antibody response to GAT-M~ other than those used for in vivo immunization and determine the mechanism by which the restriction is maintained, spleen cells from virgin and syngeneic or allogeneic GAT-M&primed mice were co-cultured in the presence of GAT-M~ of various haplotypes. Antibody responses to GAT developed only in the presence of GAT-Mq, syngeneic to the MS used for in vivo priming; responses in cultures with GAT-M~ allogeneic to the priming M4~, whether these Mq~ were syngeneic or allogeneic with respect to the responding spleen cells, were suppressed. The suppression was mediated by GAT-specific radiosensitive T cells. Thus, development of GAT-specific suppressor T cells appears to be a natural consequence of the immune response to GAT in responder as well as nonresponder mice. The implications of stimulation of genetically restricted immune helper T cells, and antigen-specific, but unrestricted, suppressor T cells after immunization with GAT-M4~ in vivo are discussed in the context of regulatory mechanisms in antibody responses.
